Skip to content
healthcare.dev

Hydralazine Hydrochloride

NDC 33342-374, Hydralazine Hydrochloride, tablet, from Macleods Pharmaceuticals Limited.

Product NDC
33342-374
Status
Listed
Labeler
Macleods Pharmaceuticals Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211010
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/33342-374 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
33342-374-1133342037411100 TABLET in 1 BOTTLE (33342-374-11)
33342-374-123334203741210 BLISTER PACK in 1 CARTON (33342-374-12) / 10 TABLET in 1 BLISTER PACK
33342-374-44333420374441000 TABLET in 1 BOTTLE (33342-374-44)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f9f56326-6d72-47d3-89ac-3625b8a6d713

Use it

Look up 33342-374 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/33342-374 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 33342-374. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.